Design of rhenium compounds in targeted anticancer therapeutics

P Collery, D Desmaele… - Current Pharmaceutical …, 2019 - ingentaconnect.com
Background: Many rhenium (Re) complexes with potential anticancer properties have been
synthesized in the recent years with the aim to overcome the clinical limitations of platinum …

Drug combination study of novel oxorhenium (V) complexes

T Petrović, N Gligorijević, F Belaj, S Aranđelović… - Journal of Inorganic …, 2022 - Elsevier
Three Re (V) complexes of structural formulas [ReOCl 2 L (PPh 3)], where L is pyridine-2-
carboxylic acid (C1), 3-methyl-pyridine-2-carboxylic acid (C2) and 6-methyl-pyridine-2 …

Differential impact on oral cancer cell viability for three carboxylate-stabilized rhenium (I) tricarbonyl centers supported by 2, 2′-bipyridine: One-pot synthesis, a …

L Buren, E Tumbaco, A Piesco, J Irvin, TJ Emge… - Inorganica Chimica …, 2024 - Elsevier
A set of six carboxylate-stabilized rhenium (I) tricarbonyl complexes supported by a 2, 2′-
bipyridine (bpy) ligand, Re (O 2 CR)(CO) 3 (bpy)(R= H, CH 3, CHF 2, R-or S-CHBrCH (CH …

[HTML][HTML] Differential expression of efferocytosis and phagocytosis associated genes in tumor associated macrophages exposed to African American patient derived …

H Banerjee, C Krauss, M Worthington… - Journal of solid …, 2019 - ncbi.nlm.nih.gov
Macrophages are the first line of defense in the cellular environment in response to any
antigenic or foreign invasion. Since cancer cells express antigenic molecules and create a …

Exploring the Anti-cancer Properties of Rhenium-Based Complexes

C Krauss - 2022 - search.proquest.com
Cancer is a worldwide health problem and is currently the second largest cause of death in
the United States with an expected mortality rate of 608,750 people in 2021. While …